Reporting of treatment fidelity in behavioural paediatric obesity intervention trials: a systematic review

M M JaKa1,2, J L Haapala2, E S Trapl3

  • 1HealthPartners Institute, Bloomington, USA.

Insights

Reporting of treatment fidelity in pediatric obesity randomized controlled trials is inconsistent. While treatment design is often reported, delivery and enactment details are lacking, hindering intervention optimization.

Area of Science:

  • Pediatric Health
  • Behavioral Interventions
  • Obesity Research

Background:

  • Behavioral interventions show promise for pediatric obesity.
  • Optimizing these interventions requires detailed treatment fidelity information.
  • Current reporting practices for treatment fidelity in this field are largely unknown.

Purpose of the Study:

  • To systematically review and describe the methods used for reporting treatment fidelity in pediatric obesity randomized controlled trials (RCTs).
  • To identify gaps in the reporting of treatment fidelity components.
  • To provide recommendations for improving treatment fidelity reporting in future research.

Main Methods:

  • Systematic review conducted following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.
  • Treatment fidelity was double-coded using the National Institutes of Health Fidelity Framework checklist.
  • Included 300 articles representing 193 studies, with high inter-coder reliability (0.83).

Main Results:

  • Reporting of treatment design elements was high (e.g., session length designed: 77%).
  • Reporting of treatment delivery and enactment domains was low (e.g., session length delivered: 7%).
  • Few studies reported gold-standard fidelity evaluation methods like coding delivered content.
  • Higher study quality and publication frequency correlated with better fidelity reporting.

Conclusions:

  • Significant gaps exist in reporting the full spectrum of treatment fidelity in pediatric obesity RCTs.
  • There has been no improvement in reporting frequency over time.
  • Recommendations are provided to enhance the rigor of treatment fidelity measurement and reporting in pediatric obesity research.